Published on 30 May 2024 on Simply Wall St. via Yahoo Finance
Shareholders May Be More Conservative With Mirum Pharmaceuticals, Inc.'s (NASDAQ:MIRM) CEO...
Key Insights
Mirum Pharmaceuticals' Annual General Meeting to take place on 5th of JuneTotal pay for CEO Chris Peetz includes US$660.0k salaryThe overall pay is 52% above the industry averageMirum Pharmaceuticals' total shareholder return over the past three years was 50% while its EPS grew by 6.8% over the past three years
Under the guidance of CEO Chris Peetz, Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) has performed reasonably well recently. As shareholders go into the upcoming AGM on 5th of June, CEO compensation will probably not be their focus, but rather the steps management will take to continue the growth momentum. However, some shareholders may still be hesitant of being overly generous with CEO compensation.